CUSIP 037326105COMANTXQ4 2025
41 filings · latest Mar 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Almitas Capital LLC | 1.48M | $1.69M |
| 2 | Vanguard Group Inc | 1.08M | $1.23M |
| 3 | Pfizer Inc | 715.3K | $815.4K |
| 4 | Stonepine Capital Management, LLC | 627.7K | $715.5K |
| 5 | Peapod Lane Capital LLC | 593.4K | $676.5K |
| 6 | Bank Of Nova Scotia | 459.2K | $523.5K |
| 7 | Landscape Capital Management, L.L.C. | 431.8K | $492.2K |
| 8 | Bank Of Montreal /Can/ | 422.1K | $481.2K |
| 9 |
| 4 | Feb 13, 2026 | Eric Easom | 13G/A | 7.9% | 2.23M | SEC |
| 5 | Nov 14, 2025 | Almitas Capital LLC | 13G | 11.0% | 1.43M | SEC |
| 6 | Jun 18, 2025 | Bml Investment Partners, L.P. | 13D/A | 1.4% | — | SEC |
| 7 | Jun 4, 2025 | Coastlands Capital LP | 13G | 9.3% | — | SEC |
| 8 | May 30, 2025 | Bml Investment Partners, L.P. | 13D/A | 10.7% | — | SEC |
| 9 | May 7, 2025 | Bml Investment Partners, L.P. | 13D | 19.1% | — | SEC |
| 10 | Feb 28, 2025 | Adjuvant Global Health Technology Fund, L.P. | 13G/A | 7.9% | 2.37M | SEC |
See the full Schedule 13D/13G history for An2 Therapeutics Inc.
Unlock full history| 385.3K |
| $439.3K |
| 10 | Renaissance Technologies LLC | 338.6K | $386.0K |